Al-Takaful Palestinian Insurance (XPAE:TIC) Research & Development: $0.00 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAE:TIC Al-Takaful Palestinian Insurance XPAE:TIC
94 GF Score
Price $2.90
GF Value $2.95
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Al-Takaful Palestinian Insurance Research & Development?

Al-Takaful Palestinian Insurance XPAE:TIC 94 Research & Development is $0.00 Mil as of Mar. 2026. GuruFocus rates XPAE:TIC with a GF Score™ of 94/100 and a GF Value™ of $2.95 (Fairly Valued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Al-Takaful Palestinian Insurance's Research & Development for the three months ended in Mar. 2026 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00 Mil.

Al-Takaful Palestinian Insurance  (XPAE:TIC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Al-Takaful Palestinian Insurance Research & Development Related Terms

Al-Takaful Palestinian Insurance Research & Development Historical Data

* Premium members only.

The historical data trend for Al-Takaful Palestinian Insurance's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Al-Takaful Palestinian Insurance Research & Development Chart

Al-Takaful Palestinian Insurance Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Al-Takaful Palestinian Insurance Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XPAE:TIC
94GF Score
Al-Takaful Palestinian Insurance XPAE:TIC
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Al-Takaful Palestinian Insurance Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Al-Takaful Palestinian Insurance (XPAE:TIC) has a Research & Development of $0.00 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Al-Takaful Palestinian Insurance and its competitors.
Is Al-Takaful Palestinian Insurance's Research & Development too high?
Al-Takaful Palestinian Insurance's current Research & Development is $0.00 Mil. Overall, Al-Takaful Palestinian Insurance has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Al-Takaful Palestinian Insurance's Research & Development compare to BRK.A and AIG?
Al-Takaful Palestinian Insurance's Research & Development of $0.00 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Al-Takaful Palestinian Insurance and its competitors. Al-Takaful Palestinian Insurance's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Al-Takaful Palestinian Insurance stock overvalued right now?
Based on GuruFocus' analysis, Al-Takaful Palestinian Insurance (XPAE:TIC) is currently considered Fairly Valued. The stock's GF Value™ is $2.95, compared to a current price of $2.90 — trading 1.7% below its estimated fair value. The current Research & Development is $0.00 Mil. Al-Takaful Palestinian Insurance's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Al-Takaful Palestinian Insurance (XPAE:TIC), the current Research & Development is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Al-Takaful Palestinian Insurance (XPAE:TIC) Overvalued in 2026?

Based on GuruFocus' analysis, Al-Takaful Palestinian Insurance stock appears to be undervalued. The current stock price of $2.90 is trading 1.7% below its estimated GF Value™ of $2.95. GuruFocus considers Al-Takaful Palestinian Insurance to be Fairly Valued.

Key valuation signals for XPAE:TIC:

  • Research & Development: $0.00 Mil
  • GF Value™: $2.95 vs. price of $2.90 (1.7% below fair value)
  • GF Score™: 94/100 with 3 warning signs

No single metric tells the full story. See the XPAE:TIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Al-Takaful Palestinian Insurance Business Description

Address Abraj House, Box: 1444, Ein Munjed, 2nd Floor, Ramallah, PSE
Al-Takaful Palestinian Insurance is a Palestine-based company that is engaged in providing multiple insurance programs and services that is compliant with Shariah. The company provides Medical insurance, which provides insurance for general and physician doctors, pharmacies, laboratories, and X-rays; Motor insurance, which provides insurance for theft, collision, and fire; Family insurance, which provides insurance for natural death, accidental death, and other; and General insurance.
94GF Score

Get the complete analysis for XPAE:TIC

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.90
Price
$2.95
GF Value